Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35

Stock ABIONYX PHARMA (FR0012616852)

Sector : Pharmaceuticals & Biotechnology – Indices : CAC ALL-TRADABLE, CAC ALL SHARES

Price 3,60 €
Daily change -1,10 %
1 week -5,39 %
1 month 0,00 %
1 year +193,60 %

Last update : 24/04/2026 at 17:35:13 – Source: Euronext

Assurance vie

Market summary

As of 24/04/2026, stock ABIONYX PHARMA trades at 3,60 € , with a change of -1,10 % , and a market cap of 128 M€.

Open0,00 €
Previous close3,64 €
Volume87 240
Market cap128 M€
P/EN/A
Dividend / shareN/A
Float turnover0,00 %
MarketEuronext PARIS
Eligible PEA, SRD

Price and moving averages

Technical analysis ABIONYX PHARMA

50-day moving average3,46 €4.05 % (above) Pivot3,59 €
Support level3 €-16.67 % Resistance level3,91 €+8.61 %
1-month volatility23,00 % Annualised volatility79,66 %
RSI (14d)50 Neutral Stochastic signal (14d)Neutre
ATR (14d)0,16 Low volatility CMF (21d)0,06 Weak buying pressure
Bollinger bands (20d) Neutral OBV (21d) Neutral (OBV stable)

Analyst consensus and recommendations

Insufficient data.

No analyst recommendation available.

Stock history and statistics

IPO dateMar 25, 2015
52-week high4,15 €52-week low2,92 €
All-time high14,44 €All-time low0,20 €
1-year volatility79,66 %Beta0,33

Financial calendar — ABIONYX PHARMA

📅
March 12, 2026 Annual results 2025
📅
May 28, 2026 Revenue du Q1 2026
📅
August 27, 2026 Revenue du Q2 2026
📅
September 24, 2026 RESULTATS SEMESTRIELS 2026
📅
November 26, 2026 Revenue du Q3 2026

Recent news — ABIONYX PHARMA

ABIONYX Pharma announces the development of a new manufacturing process for synthetic sphingomyelin, a key component of its CER-001 product for sepsis…

ABIONYX Pharma announces its annual results for 2025 and outlines its strategic directions focused on actively preparing for the next clinical phase i…

Latest earnings

Annuels 2025
Revenue 4 M€
-10,9 %
EBITDA -5 M€
Net income -6 M€
-25,0 %
EPS (diluted) -0,13 €

Analyses on ABIONYX PHARMA stock

No analysis has been published on this stock yet.

Frequently asked questions about ABIONYX PHARMA stock

What does the recent price action of ABIONYX PHARMA stock show?

ABIONYX PHARMA stock is currently trading around 3,60 €, down 1,10% and down 0,05% over one week.

Is ABIONYX PHARMA stock in a support or resistance zone?

Technical levels help place the stock. Support: 3,00 €. Resistance: 3,91 €.

How should the current volatility of ABIONYX PHARMA stock be interpreted?

Volatility is around 79,66%.

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA
BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit